A significant breakthrough in cancer study is arising with the use of mini-antibodies to re-engage damaged p53. This essential tumor inhibitor protein is frequently disabled in various kinds of cancer, resulting https://push2bookmark.com/story22130739/nanobodies-revive-the-p53-protein-new-promising-pathway-for-malignant-treatment